Cargando…
Ticagrelor Increases SIRT1 and HES1 mRNA Levels in Peripheral Blood Cells from Patients with Stable Coronary Artery Disease and Chronic Obstructive Pulmonary Disease
Ticagrelor is a powerful P2Y(12) inhibitor with pleiotropic effects in the cardiovascular system. Consistently, we have reported that in patients with stable coronary artery disease (CAD) and concomitant chronic obstructive pulmonary disease (COPD) who underwent percutaneous coronary intervention (P...
Autores principales: | Aquila, Giorgio, Vieceli Dalla Sega, Francesco, Marracino, Luisa, Pavasini, Rita, Cardelli, Laura Sofia, Piredda, Anna, Scoccia, Alessandra, Martino, Valeria, Fortini, Francesca, Bononi, Ilaria, Martini, Fernanda, Manfrini, Marco, Pannuti, Antonio, Ferrari, Roberto, Rizzo, Paola, Campo, Gianluca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084534/ https://www.ncbi.nlm.nih.gov/pubmed/32106619 http://dx.doi.org/10.3390/ijms21051576 |
Ejemplares similares
-
Ticagrelor Improves Endothelial Function by Decreasing Circulating Epidermal Growth Factor (EGF)
por: Vieceli Dalla Sega, Francesco, et al.
Publicado: (2018) -
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease
por: Campo, Gianluca, et al.
Publicado: (2017) -
Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review
por: Papa, Veronica, et al.
Publicado: (2020) -
Notch Signaling Regulates Immune Responses in Atherosclerosis
por: Vieceli Dalla Sega, Francesco, et al.
Publicado: (2019) -
Characterization of the Notch pathway in nasal polyps of patients with chronic rhinosinusitis: A pilot study
por: Aquila, Giorgio, et al.
Publicado: (2022)